Anupam Rasayan India ANURAS
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Anupam Rasayan India's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
AI analysis and Advanced tools for ANURAS
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 8,012.6 | 5,268.88 | 4,601.67 |
| Cash Equivalents | 393.63 | 7 | 6.35 |
| Other Liabilities Total | 46.93 | 45.55 | 1.48 |
| Long Term Debt | 510.85 | 164.3 | 194.42 |
| Common Stock Total | 145.76 | 109.93 | 109.79 |
| Other Current Assets Total | 569.76 | 6.48 | 5.53 |
| Total Assets | 8,012.6 | 5,268.88 | 4,601.67 |
| Current Portof LT Debt/Capital Leases | 1,308.07 | 121.37 | 133.9 |
| Total Equity | 3,333.75 | 2,850.31 | 2,761.02 |
| Long Term Investments | 138.26 | 1.81 | 1.45 |
| Retained Earnings(Accumulated Deficit) | 3,187.99 | 928.55 | 842.82 |
| Total Common Shares Outstanding | 11.38 | 10.99 | 10.98 |
| Tangible Book Valueper Share Common Eq | 228.46 | 245.99 | 238.32 |
| Goodwill Net | 663.46 | 123.21 | 123.21 |
| Total Liabilities | 4,678.85 | 2,418.57 | 1,840.64 |
| Total Debt | 1,867.49 | 1,373.38 | 1,069.06 |
| Short Term Investments | 21.82 | 7.83 | 98.11 |
| Cashand Short Term Investments | 415.45 | 128.24 | 349.83 |
| Total Receivables Net | 967.55 | 959.82 | 797.05 |
| Deferred Income Tax | 160.86 | 110.49 | 116.39 |
| Accounts Receivable-Trade Net | 959.39 | 733.76 | 579.39 |
| Property/Plant/Equipment Total-Net | 3,094.49 | 2,254.53 | 1,966.15 |
| Minority Interest | 1,296.21 | 231.34 | 169.63 |
| Total Current Liabilities | 2,615.44 | 1,808.21 | 1,316.17 |
| Total Inventory | 1,774.75 | 1,451.5 | 1,055.32 |
| Accounts Payable | 945.53 | 576.38 | 415.19 |
| Other Currentliabilities Total | 361.84 | 70.58 | 60.36 |
| Total Long Term Debt | 559.42 | 222.99 | 236.96 |
| Intangibles Net | 69.28 | 22.96 | 21.4 |
| Other Long Term Assets Total | 304.98 | 125.47 | 127.81 |
| Note Receivable-Long Term | 14.63 | 167.88 | 135.04 |
| Total Current Assets | 3,727.51 | 2,573.04 | 2,226.62 |
| Capital Lease Obligations | 48.57 | 58.68 | 42.54 |
| Accumulated Depreciation Total | Not available | -586.66 | -486.59 |
| Accrued Expenses | Not available | 10.86 | 8.52 |
| Other Equity Total | Not available | 0.18 | 0.52 |
| Prepaid Expenses | Not available | 27 | 18.88 |
| Additional Paid-In Capital | Not available | 1,811.66 | 1,807.9 |
| Cash | Not available | 113.41 | 245.38 |
| Property/Plant/Equipment Total-Gross | Not available | 2,625.02 | 1,843.39 |
| Notes Payable/Short Term Debt | Not available | 1,029.03 | 698.2 |
Valuation and ratios
Growth
Debt 5Yr CAGR %34.57
Margins
Operating Margin 12m16.27
Operating Margin 5y Avg19.93
Net Profit Margin 12m9.39
Net Profit Margin 5y11.56
Yield
Dividend Yield %0.12
Valuation
Price to Sale Ratio5.83
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk25.01
Analyst consensus
ConsensusHold
Consensus score3.00
Analyst opinions5
Strong Sell count2
Sell count0
Hold count0
Buy count2
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Ownership
- Promoter
- 59.07%
- FII
- 7.72%
- MF
- 0.19%
- Other
- 33.02%
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Anupam Rasayan Acquires 100% Stake In Mates Visa As PAC For Bliss GVS Acquisition Sahi
Anupam Rasayan signs USD 300 mn LOI with Spain's BasqueVolt for battery chemical supply The Economic Times
Anupam Rasayan signs $300 million deal with Spain’s BASQUEVOLT for solid-state battery chemicals Indian Chemical News
Anupam Rasayan Signs Rs 2,885 Cr Battery Chem Deal Equitypandit
Anupam Rasayan inks ₹2,885 crore battery chemical LoI MSN
Events
- dividendRs.1.5000 per share(15%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingPOM
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- dividendRs.0.7500 per share(7.5%)Interim Dividend
- board MeetingsInterim Dividend & Preferential issue
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.0.7500 per share(7.5%)Final Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
Discussion and sentiment for Anupam Rasayan India
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Community discussion loads as you approach this section.
Business information
What the company does
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- ANURAS
- BSE Code
- 543275
Stock FAQ
What is the symbol and ISIN of Anupam Rasayan India?
Anupam Rasayan India has the symbol ANURAS and ISIN - INE930P01018.
What is the latest recorded price of Anupam Rasayan India?
The latest available recorded price of Anupam Rasayan India is INR 1,210.60 as of 2026-08-06T20:56:30.561Z. This is a source-stamped snapshot, not a live quote.
What are the year high and year low of Anupam Rasayan India?
Year high: INR 1,415.40. Year low: INR 1,047.40.
What is the market capitalization of Anupam Rasayan India?
Market capitalization: INR 13,787.03 crore.
What is the P/E ratio of Anupam Rasayan India?
P/E ratio: 81.57.
What is the dividend yield of Anupam Rasayan India?
Dividend yield: 0.12%.
How is the financial performance of Anupam Rasayan India based on revenue, net income, and EPS?
Revenue: INR 2,365.46 crore. Net income: INR 170.12 crore. EPS: INR 15.09.
What is the book value of Anupam Rasayan India?
Book value: INR 228.46.
What are the price-to-book and price-to-sales ratios of Anupam Rasayan India?
Price-to-book ratio: 5.30. Price-to-sales ratio: 5.83.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.

